
GC33049
FN-1501
Also known as N-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]-4-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1H-pyrazole-5-carboxamide
FN-1501 is a potent inhibitor of FLT3 and CDK, with IC50s of 2·47, 0·85, 1·96, and 0·28 nM for CDK2/cyclin A, CDK4/cyclin D1, CDK6/cyclin D1 and FLT3, respectively· FN-1501 has anticancer activity
ChemicalCAS1429515-59-2MW431.49FormulaC22H25N9O
- CAS number
- 1429515-59-2
- Molecular weight
- 431.49
- Formula
- C22H25N9O
- Solubility
- DMSO : ≥ 50 mg/mL (115·88 mM)
- InChIKey
- VXLAKHWYGRKCGI-UHFFFAOYSA-N
- Catalogue number
- GC33049
- Brand
- GLPBIO
Computed properties PubChem CID 72195175 · XLogP 2.2 · TPSA 118 Ų · H-bond donors 4
- XLogP
- 2.2
- TPSA
- 118 Ų
- H-bond donors
- 4
- H-bond acceptors
- 7
- Rotatable bonds
- 6
- Heavy atoms
- 32
SMILES CN1CCN(CC1)CC2=CC=C(C=C2)NC(=O)C3=C(C=NN3)NC4=NC=NC5=C4C=CN5
Computed descriptors from PubChem (CID 72195175), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il